UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 365

Sortiert nach

Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease

Modern pathology, 2017-10, Vol.30 (10), p.1367-1377

2017

Volltextzugriff (PDF)

Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients

Leukemia, 2022-05, Vol.36 (5), p.1343-1350

2022

Volltextzugriff (PDF)

MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas

Modern pathology, 2018-09, Vol.31 (9), p.1470-1478

2018

Volltextzugriff (PDF)

Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge

Modern pathology, 2022-03, Vol.35 (3), p.419-426

2022

Volltextzugriff (PDF)

PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma

Modern pathology, 2020-03, Vol.33 (3), p.324-333

2020

Volltextzugriff (PDF)

Myelofibrosis osteoclasts are clonal and functionally impaired

Blood, 2019-05, Vol.133 (21), p.2320-2324

2019

Volltextzugriff (PDF)

Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm

Cancers, 2021-11, Vol.13 (23), p.5888

2021

Volltextzugriff (PDF)

MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma

Haematologica (Roma), 2021-05, Vol.106 (5), p.1381

2021

Volltextzugriff (PDF)

Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor

Annals of oncology, 2018-08, Vol.29 (8), p.1880-1882

2018

Volltextzugriff (PDF)

GLI1 activates pro-fibrotic pathways in myelofibrosis fibrocytes

Cell death & disease, 2022-05, Vol.13 (5), p.481-481, Article 481

2022

Volltextzugriff (PDF)

DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high‐risk disease

American journal of hematology, 2019-07, Vol.94 (7), p.757-766

2019

Volltextzugriff (PDF)

Acute myeloid leukemia with inversion 16 and a novel PTPN11 mutation: A case report with literature review

International journal of laboratory hematology, 2024-02, Vol.46 (1), p.195-198

2024

Volltextzugriff (PDF)

Unique blast phase of chronic myeloid leukemia with concurrent erythroid and megakaryocytic differentiation

International journal of laboratory hematology, 2024-02, Vol.46 (1), p.5-7

2024

Volltextzugriff (PDF)

Polarization Sensitive Photothermal Mid-Infrared Spectroscopic Imaging of Human Bone Marrow Tissue

Applied spectroscopy, 2022-04, Vol.76 (4), p.508-518

2022

Volltextzugriff (PDF)

Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes

Haematologica (Roma), 2018-02, Vol.103 (2), p.278

2018

Volltextzugriff (PDF)

ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia

Cancer, 2023-03, Vol.129 (6), p.878-889

2023

Volltextzugriff (PDF)

Persistent IDH1/2 mutations in remission can predict relapse in patients with acute myeloid leukemia

Haematologica (Roma), 2019-02, Vol.104 (2), p.305

2019

Volltextzugriff (PDF)

Genotype‐phenotype correlation of unusual BCR‐ABL1 transcripts in Philadelphia chromosome‐positive leukaemia

British journal of haematology, 2020-06, Vol.189 (5), p.e207-e211

2020

Volltextzugriff (PDF)

Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) ‐ outcomes and mutation profile from venetoclax resistant MCL patients

American journal of hematology, 2020-06, Vol.95 (6), p.623-629

2020

Volltextzugriff (PDF)

iAMP21 in acute myeloid leukemia is associated with complex karyotype, TP53 mutation and dismal outcome

Modern pathology, 2020-07, Vol.33 (7), p.1389-1397

2020

Volltextzugriff (PDF)

High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis

The American journal of surgical pathology, 2016-02, Vol.40 (2), p.253-261

2016

Volltextzugriff (PDF)

Focal Rosai-Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation

Modern pathology, 2019-01, Vol.32 (1), p.16-26

2019

Volltextzugriff (PDF)

1 – 25 von 365

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(325)
Mit Volltextzugriff
(337)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(44)
Modern Pathology
(27)
American Journal Of Clinical Pathology
(17)
Cancer
(12)
American Journal Of Hematology
(11)
Clinical Lymphoma, Myeloma And Leukemia
(11)
Human Pathology
(10)
Oncotarget
(10)
Cancers
(9)
The American Journal Of Surgical Pathology
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease

Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients

MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas

Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study

Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge

Cyclin D1 expression in Rosai-Dorfman disease: a near-constant finding that is not invariably associated with mitogen-activated protein kinase/extracellular signal–regulated kinase pathway activation

PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma

Myelofibrosis osteoclasts are clonal and functionally impaired

Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm

MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma

Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor

GLI1 activates pro-fibrotic pathways in myelofibrosis fibrocytes

DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high‐risk disease

Acute myeloid leukemia with inversion 16 and a novel PTPN11 mutation: A case report with literature review

Unique blast phase of chronic myeloid leukemia with concurrent erythroid and megakaryocytic differentiation

Polarization Sensitive Photothermal Mid-Infrared Spectroscopic Imaging of Human Bone Marrow Tissue

Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes

ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia

Persistent IDH1/2 mutations in remission can predict relapse in patients with acute myeloid leukemia

Genotype‐phenotype correlation of unusual BCR‐ABL1 transcripts in Philadelphia chromosome‐positive leukaemia

Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) ‐ outcomes and mutation profile from venetoclax resistant MCL patients

iAMP21 in acute myeloid leukemia is associated with complex karyotype, TP53 mutation and dismal outcome

High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis

Ibrutinib–rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial

Focal Rosai-Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation

Suchergebnisse filtern